Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-030837
Filing Date
2021-07-30
Accepted
2021-07-30 17:05:13
Documents
1
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4110
  Complete submission text file 0000899243-21-030837.txt   5488
Mailing Address C/O ELEVEN BIOTHERAPEUTICS, INC. 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142
Business Address
BERRY DAVID A (Reporting) CIK: 0001204876 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40657 | Film No.: 211133408

Mailing Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 20 ACORN PARK DRIVE CAMBRIDGE MA 02140 (617) 949-4360
Omega Therapeutics, Inc. (Issuer) CIK: 0001850838 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)